Living drugs that reprogram patients' immune cells show early promise against hard-to-treat brain tumors
Three studies published within the past week have reported dramatic results with a therapy called CAR-T delivered directly to the brain. In some cases, tumors have seemingly melted away on brain scans by the next day.